Back to Search

RAFAEL JOVE, M.D.

M.D.

Specialist

NPI: 1093797102Individual

Specialties, Licenses & Credentials

SpecialistPrimary

Specialist

Code: 174400000X

4191(PR)

Research & Publications (20)

Preface: STAT signaling.
PMID 10851044·Oncogene·2000
7-preclinical
Stat3 activity is required for gap junctional permeability in normal rat liver epithelial cells.
PMID 19456249·DNA Cell Biol·2009
7-preclinical
Beta1 integrin adhesion enhances IL-6-mediated STAT3 signaling in myeloma cells: implications for microenvironment influence on tumor survival and proliferation.
PMID 19155309·Cancer Res·2009
8-other
Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.
PMID 19434004·Melanoma Res·2009
8-other
Persistently activated Stat3 maintains constitutive NF-kappaB activity in tumors.
PMID 19345327·Cancer Cell·2009
7-preclinical
The high-mobility group A1a/signal transducer and activator of transcription-3 axis: an achilles heel for hematopoietic malignancies?
PMID 19074878·Cancer Res·2008
7-preclinical
Effects of dasatinib on SRC kinase activity and downstream intracellular signaling in primitive chronic myelogenous leukemia hematopoietic cells.
PMID 19047139·Cancer Res·2008
8-other
Activated stat-3 in melanoma.
PMID 18596671·Cancer Control·2008
4-observational
Inhibition of Src family kinases with dasatinib blocks migration and invasion of human melanoma cells.
PMID 19010823·Mol Cancer Res·2008
8-other
The novel histone deacetylase inhibitor, LBH589, induces expression of DNA damage response genes and apoptosis in Ph- acute lymphoblastic leukemia cells.
PMID 18349321·Blood·2008
8-other

Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.

Contact & Hours

Address
CALLE ANTONIO R. BARCELO #109, SUITE 3
ARECIBO, PR 00612

Quick Facts

NPI
1093797102
Entity Type
Individual
Gender
Male
Medicare
Not confirmed
Specialties
1
Locations
1
Publications
20

Are you this provider?

Claim Your Profile